Aurora Cannabis (TSX: ACB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.14) by 242.86 percent. This is a 37.14 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $84.816 million which beat the analyst consensus estimate of $75.200 million by 12.79 percent. This is a 6.32 percent decrease over sales of $90.538 million the same period last year.